P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3-MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUP

Bibliographic Details
Main Authors: Francesco Marchesi, Pierantonio Menna, Chiara Cattaneo, Anna Candoni, Mario Delia, Gianpaolo Nadali, Crescenza Pasciolla, Salvatore Perrone, Luisa Verga, Daniele Armiento, Maria Ilaria DEL Principe, Nicola Stefano Fracchiolla, Emanuela Salvatorelli, S Lupisella, Irene Terrenato, Alessandro Busca, Livio Pagano
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000968856.99922.98
_version_ 1797279869377183744
author Francesco Marchesi
Pierantonio Menna
Chiara Cattaneo
Anna Candoni
Mario Delia
Gianpaolo Nadali
Crescenza Pasciolla
Salvatore Perrone
Luisa Verga
Daniele Armiento
Maria Ilaria DEL Principe
Nicola Stefano Fracchiolla
Emanuela Salvatorelli
S Lupisella
Irene Terrenato
Alessandro Busca
Livio Pagano
author_facet Francesco Marchesi
Pierantonio Menna
Chiara Cattaneo
Anna Candoni
Mario Delia
Gianpaolo Nadali
Crescenza Pasciolla
Salvatore Perrone
Luisa Verga
Daniele Armiento
Maria Ilaria DEL Principe
Nicola Stefano Fracchiolla
Emanuela Salvatorelli
S Lupisella
Irene Terrenato
Alessandro Busca
Livio Pagano
author_sort Francesco Marchesi
collection DOAJ
first_indexed 2024-03-07T16:33:12Z
format Article
id doaj.art-1aeb9327e7394d63995b2b789ac8238f
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:33:12Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-1aeb9327e7394d63995b2b789ac8238f2024-03-03T10:07:30ZengWileyHemaSphere2572-92412023-08-017e999229810.1097/01.HS9.0000968856.99922.98202308003-00388P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3-MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUPFrancesco Marchesi0Pierantonio Menna1Chiara Cattaneo2Anna Candoni3Mario Delia4Gianpaolo Nadali5Crescenza Pasciolla6Salvatore Perrone7Luisa Verga8Daniele Armiento9Maria Ilaria DEL Principe10Nicola Stefano Fracchiolla11Emanuela Salvatorelli12S Lupisella13Irene Terrenato14Alessandro Busca15Livio Pagano161 IRCCS Regina Elena National Cancer Institute2 Campus Bio-Medico University3 Spedali Civili, Brescia4 Modena and Reggio Emilia University5 Azienda Ospedaliero Universitaria Consorziale Policlinico, Bari,6 Azienda Ospedaliera Universitaria Integrata, Verona7 IRCCS Istituto Tumori “Giovanni Paolo II”, Bari8 Polo Universitario Pontino, S.M. Goretti Hospital, Latina9 Azienda Ospedaliera San Gerardo - Monza,2 Campus Bio-Medico University10 Tor Vergata University, Rome11 Fondazione IRCCS Ca’ Grande Ospedale Maggiore Policlinico, Milan2 Campus Bio-Medico University2 Campus Bio-Medico University1 IRCCS Regina Elena National Cancer Institute12 AOU Citta’ della Salute e della Scienza, Turin13 Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Romehttp://journals.lww.com/10.1097/01.HS9.0000968856.99922.98
spellingShingle Francesco Marchesi
Pierantonio Menna
Chiara Cattaneo
Anna Candoni
Mario Delia
Gianpaolo Nadali
Crescenza Pasciolla
Salvatore Perrone
Luisa Verga
Daniele Armiento
Maria Ilaria DEL Principe
Nicola Stefano Fracchiolla
Emanuela Salvatorelli
S Lupisella
Irene Terrenato
Alessandro Busca
Livio Pagano
P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3-MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUP
HemaSphere
title P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3-MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUP
title_full P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3-MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUP
title_fullStr P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3-MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUP
title_full_unstemmed P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3-MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUP
title_short P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3-MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUP
title_sort p487 midostaurin plasma exposure in patients with flt3 mut acute myeloid leukemia undergoing posaconazole prophylaxis during induction treatment a prospective multicentre study from the seifem group
url http://journals.lww.com/10.1097/01.HS9.0000968856.99922.98
work_keys_str_mv AT francescomarchesi p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT pierantoniomenna p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT chiaracattaneo p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT annacandoni p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT mariodelia p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT gianpaolonadali p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT crescenzapasciolla p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT salvatoreperrone p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT luisaverga p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT danielearmiento p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT mariailariadelprincipe p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT nicolastefanofracchiolla p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT emanuelasalvatorelli p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT slupisella p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT ireneterrenato p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT alessandrobusca p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup
AT liviopagano p487midostaurinplasmaexposureinpatientswithflt3mutacutemyeloidleukemiaundergoingposaconazoleprophylaxisduringinductiontreatmentaprospectivemulticentrestudyfromtheseifemgroup